Speaker illustration

Doctor Ruben Schleberger

University Heart & Vascular Center Hamburg, Hamburg (Germany)

Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation has no impact on recurrences, cardiovascular events and mortality - insights from the german ablation registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Catheter Ablation of Arrhythmias

Session: Congress committee e-posters choice in arrhythmias and device therapy

Thumbnail

This platform is supported by

logo Novo Nordisk